Slide 1Vaccine development - Is there a healthy future ? On the interphase of public and private, rich and poor First EPITrain course in advanced epidemiology Jurmala Latvia…
Slide 1Statistical Issues and Challenges in Combination Vaccines Ivan S. F. Chan, Ph.D. Merck Research Laboratories Sang Ahnn, Ph.D. CBER, FDA 2005 FDA/Industry Statistics…
1. “If a lie is told loud enough and long enough people will begin to believe it” AH 2. Theory =“milk maids that got Cow Pox were protected from Small Pox” Jenner…
Hepatitis C May Nguyen, PharmD, CGP PHAS 3311 Spring 2015 Required Reading § Pharmacology for the Primary Care Provider § Unit 14, Chapter 67, 68, 69 § Lippincott’s…
Slide 1Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007 Slide 2 The GAVI Alliance Public-private partnership bringing together…
Slide 1 1 Strategies of Vaccinations - Strength in Diversity Roman Prymula Slide 2 2 Background I. Vaccines have a major impact on society. Indeed, vaccination is one…
Slide 1 By Ahmed Khaled Vaccine team Pfizer KSA [email protected] Slide 2 In the Year 2000,Prevenar was the first PCV to be licensed for the prevention of PD in children.…